A review of the pharmacokinetics and pharmacodynamics of aztreonam.

Ramsey, Christopher; MacGowan, Alasdair P

Ramsey, Christopher; MacGowan, Alasdair P.

Affiliation

Ramsey C; Department of Medical Microbiology, Southmead Hospital, Bristol Centre for Antimicrobial Research and Evaluation, Severn Infection Sciences Partnership, Westbury-on-Trym, Bristol BS10 5NB, UK christopher.ramsey@nbt.nhs.uk.
MacGowan AP; Department of Medical Microbiology, Southmead Hospital, Bristol Centre for Antimicrobial Research and Evaluation, Severn Infection Sciences Partnership, Westbury-on-Trym, Bristol BS10 5NB, UK.

J Antimicrob Chemother ; 71(10): 2704-12, 2016 10.

Article in En | MEDLINE | ID: mdl-27334663

Subject(s)

Aztreonam/pharmacokinetics; Aztreonam/therapeutic use; Gram-Negative Bacterial Infections/drug therapy; beta-Lactamase Inhibitors/pharmacokinetics; beta-Lactamase Inhibitors/therapeutic use; Aztreonam/administration & dosage; Aztreonam/pharmacology; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae/drug effects; Enterobacteriaceae/enzymology; Gram-Negative Bacteria/drug effects; Gram-Negative Bacterial Infections/microbiology; Humans; Microbial Sensitivity Tests; beta-Lactamase Inhibitors/administration & dosage; beta-Lactamase Inhibitors/pharmacology; beta-Lactamases/biosynthesis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Aztreonam / Gram-Negative Bacterial Infections / Beta-Lactamase Inhibitors Limits: Humans Language: En Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google